TSH Biopharm Corporation Limited
Quick facts
Marketed products
- Amlodipine+Benazepril · Cardiovascular
Amlodipine relaxes blood vessels by blocking calcium channels, while benazepril lowers blood pressure by inhibiting angiotensin-converting enzyme (ACE), together reducing hypertension through complementary pathways.
Phase 3 pipeline
- Corever · Other
- RANCAD · Oncology
RANCAD is a recombinant human anti-CTLA-4 monoclonal antibody that blocks the inhibitory checkpoint protein CTLA-4 to enhance anti-tumor immune responses.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- TSH Biopharm Corporation Limited portfolio CI brief
- TSH Biopharm Corporation Limited pipeline updates RSS
Frequently asked questions about TSH Biopharm Corporation Limited
What are TSH Biopharm Corporation Limited's marketed drugs?
Top marketed products include Amlodipine+Benazepril.
What is TSH Biopharm Corporation Limited's pipeline?
TSH Biopharm Corporation Limited has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Corever, RANCAD.
Related
- Amlodipine+Benazepril · Cardiovascular
- Sector hub: All tracked pharma companies